Saturday, July 5, 2025 7/5/2025

Improving Preclinical Translation in Alzheimer's Disease Research

Award Number: R13AG060708
ORGANIZATION: NATIONAL INSTITUTE ON AGING
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/01/2018
PERIOD OF PERFORMANCE END DATE: 03/31/2027

Group Awards By:

View Award Description

Improving Preclinical Translation in Alzheimer's Disease Research - PROJECT SUMMARY/ABSTRACT Our long-term goal is to ensure that rigorous, best-practice scientific methods are consistently applied in experiments generating preclinical data for potential therapies for Alzheimer’s disease (AD). The number of AD cases is rising dramatically worldwide, and there is an urgent need to develop effective new therapies beyond the modest efficacy of the current FDA approved drugs for AD. Given that data from preclinical drug screening in animal models are used to inform clinical trials in AD patients, it is critical to ensure the highest level of rigor and assurances for successful translation from animal models to human patients. Unfortunately, in preclinical drug testing studies, there has been evidence of deficiencies in experimental design, sample size, data analysis, optimization of drug screening pipelines, and experience of individuals generating the data, together indicating a need for better training in preclinical drug discovery and translational medicine methodologies and processes. Over the last three years we have successfully delivered an annual course that meets this need by providing the necessary hands-on as well as theoretical training in fundamental skillsets required for conducting rigorous in vivo studies in AD mouse models. Herein we propose to continue providing this nationally available, immersion workshop focused on Principles and Techniques for Improving Preclinical Translation of Alzheimer’s Disease Research, to be held at The Jackson Laboratory (JAX) in Bar Harbor, ME that will leverage the expertise of the Indiana University (IU)/JAX/University of Pittsburgh (PITT) Model Organism Development for Evaluation of Late Onset Alzheimer’s Disease (MODEL-AD) consortium. This training collaboration will convene experts with diverse complementary skills ranging from mouse genetics to statistics to preclinical testing at a state-of-the-art residential conference center and hands-on training facility for mice at JAX. The workshop will ensure a diverse group across professional levels and have appropriate representation of traditionally underrepresented individuals as workshop participants, and supported by scholarships. In line with the NIH initiative on rigor and reproducibility, the workshop aims to address training gaps in preclinical drug screening by providing participants with the skills and knowledge required for rigorous design, execution, analysis, and reporting of pharmacokinetic, pharmacodynamics, and preclinical efficacy experiments. The workshop is innovative in that it includes a significant amount of hands-on, practical laboratory training in in vivo drug screening methodologies. The specific aims of the workshop are to 1) Train participants in the rigorous design, experimental execution, analysis, and reporting of data in line with the ARRIVE guidelines for preclinical testing of AD therapies. 2) Provide participants with the practical laboratory tools and skills to perform rigorous, reproducible preclinical tests on mouse models of AD. 3) Promote interaction and discussion between faculty and students to foster open, honest dialogue and collaborative research across a diversity of participant backgrounds. Our innovative and comprehensive workshop will offer a critical, unique hands-on training experience that is possible only at JAX.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = $49,394 )
2024	2024	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION	4200 FIFTH AVENUE	PITTSBURGH	PA	15260	ALLEGHENY	USA	Aging Research	000	6	3/28/2024	NON-COMPETING CONTINUATION	$49,394
														Subtotal = $49,394

Issue Date FY: 2023 ( Subtotal = $49,394 )
2023	2023	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION	4200 FIFTH AVENUE	PITTSBURGH	PA	15260	ALLEGHENY	USA	Aging Research	000	5	3/15/2023	NON-COMPETING CONTINUATION	$49,394
2023	2022	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION	4200 FIFTH AVENUE	PITTSBURGH	PA	15260	ALLEGHENY	USA	Aging Research	002	4	6/16/2023	COMPETING CONTINUATION	$8
2023	2020	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION	4200 FIFTH AVENUE	PITTSBURGH	PA	15260	ALLEGHENY	USA	Aging Research	001	3	6/16/2023	NON-COMPETING CONTINUATION	-$8
														Subtotal = $49,394

Issue Date FY: 2022 ( Subtotal = $49,394 )
2022	2022	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION	4200 FIFTH AVENUE	PITTSBURGH	PA	15260	ALLEGHENY	USA	Aging Research	004	4	8/26/2022	COMPETING CONTINUATION	$34,757
2022	2022	UNIVERSITY OF PITTSBURGH, THE	4200 5TH AVE	PITTSBURGH	PA	15260	ALLEGHENY	USA	Aging Research	002	4	3/25/2022	COMPETING CONTINUATION	$49,394
2022	2020	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION	4200 FIFTH AVENUE	PITTSBURGH	PA	15260	ALLEGHENY	USA	Aging Research	003	3	8/26/2022	NON-COMPETING CONTINUATION	-$34,757
2022	2020	UNIVERSITY OF PITTSBURGH, THE	4200 5TH AVE	PITTSBURGH	PA	15260	ALLEGHENY	USA	Aging Research	001	3	3/24/2022	NON-COMPETING CONTINUATION	$0
2022	2020	UNIVERSITY OF PITTSBURGH, THE	4200 5TH AVE	PITTSBURGH	PA	15260	ALLEGHENY	USA	Aging Research	000	3	10/19/2021	NON-COMPETING CONTINUATION	$0
														Subtotal = $49,394

Issue Date FY: 2020 ( Subtotal = $48,965 )
2020	2020	UNIVERSITY OF PITTSBURGH THE	3520 FIFTH AVE	PITTSBURGH	PA	15213	ALLEGHENY	USA	Aging Research	002	3	8/12/2020	NON-COMPETING CONTINUATION	$48,965
2020	2019	UNIVERSITY OF PITTSBURGH THE	3520 FIFTH AVE	PITTSBURGH	PA	15213	ALLEGHENY	USA	Aging Research	001	2	1/13/2020	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$18,095
2020	2018	THE JACKSON LABORATORY	600 MAIN ST	BAR HARBOR	ME	04609	HANCOCK	USA	Aging Research	000	1	1/13/2020	NEW	-$18,095
														Subtotal = $48,965

Issue Date FY: 2019 ( Subtotal = $49,139 )
2019	2019	UNIVERSITY OF PITTSBURGH THE	3520 FIFTH AVE	PITTSBURGH	PA	15213	ALLEGHENY	USA	Aging Research	001	2	8/2/2019	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$49,139
2019	2018	THE JACKSON LABORATORY	600 MAIN ST	BAR HARBOR	ME	04609	HANCOCK	USA	Aging Research	000	1	7/31/2019	NEW	$0
														Subtotal = $49,139

Issue Date FY: 2018 ( Subtotal = $49,139 )
2018	2018	THE JACKSON LABORATORY	600 MAIN ST	BAR HARBOR	ME	04609	HANCOCK	USA	Aging Research	000	1	8/21/2018	NEW	$49,139
														Subtotal = $49,139

Grand Total All Awards = $295,425

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Improving Preclinical Translation in Alzheimer's Disease Research

Award Number: R13AG060708

ORGANIZATION: NATIONAL INSTITUTE ON AGING

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/01/2018

PERIOD OF PERFORMANCE END DATE: 03/31/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer